Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-02-06 Sale |
2023-02-07 5:36 pm |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
2,079 | $40.59 | $84,392 | 75,496 (Direct) |
View |
2023-02-06 Sale |
2023-02-07 5:36 pm |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
1,920 | $40.66 | $78,070 | 72,385 (Direct) |
View |
2023-02-06 Sale |
2023-02-07 5:36 pm |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
1,451 | $40.66 | $58,997 | 21,227 (Direct) |
View |
2023-02-06 Sale |
2023-02-07 5:36 pm |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
1,813 | $40.57 | $73,560 | 69,651 (Direct) |
View |
2023-01-30 Sale |
2023-02-02 1:48 pm |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
9,000 | $39.56 | $356,072 | 39,679 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:22 pm |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
5,631 | $39.74 | $223,800 | 73,438 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:22 pm |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
4,752 | $39.57 | $188,052 | 62,396 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:21 pm |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
7,836 | $39.49 | $309,480 | 96,334 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:21 pm |
IONIS PHARMACEUTICALS INC | IONS | Monia Brett P Chief Executive Officer |
25,066 | $39.49 | $989,947 | 297,724 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
8,280 | $39.7 | $328,721 | 125,578 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
7,873 | $39.57 | $311,525 | 116,560 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
3,748 | $39.55 | $148,223 | 73,864 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
6,978 | $38.89 | $271,356 | 89,269 (Direct) |
View |
2023-01-18 Sale |
2023-01-19 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | Baroldi Joseph EVP, Chief Business Officer |
375 | $39.79 | $14,920 | 8,426 (Indirect Direct) |
View |
2023-01-17 Sale |
2023-01-18 8:19 pm |
IONIS PHARMACEUTICALS INC | IONS | KLEIN JOSEPH III Director |
2,000 | $40 | $80,000 | 22,891 (Indirect Direct) |
View |
2022-09-08 Sale |
2022-09-12 7:09 pm |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
460 | $44.55 | $20,493 | 19,892 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-02-03 Option Award |
2023-02-07 5:36 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
4,140 | $0 | 75,496 (Direct) |
View |
2023-02-03 Option Award |
2023-02-07 5:36 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
3,822 | $0 | 72,385 (Direct) |
View |
2023-02-03 Option Award |
2023-02-07 5:36 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
4,140 | $0 | 21,227 (Direct) |
View |
2023-02-03 Option Award |
2023-02-07 5:36 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
3,609 | $0 | 69,651 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:22 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
15,780 | $0 | 73,438 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:22 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
13,046 | $0 | 62,396 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:21 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
21,871 | $0 | 96,334 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:21 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Monia Brett P Chief Executive Officer |
57,267 | $0 | 297,724 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
23,154 | $0 | 125,578 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
21,983 | $0 | 116,560 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
10,197 | $0 | 73,864 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
19,417 | $0 | 89,269 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Baroldi Joseph EVP, Chief Business Officer |
904 | $0 | 8,426 (Indirect) |
View |
2023-01-15 Option Award |
2023-01-18 8:23 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
30,043 | $0 | 65,313 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:22 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
31,626 | $0 | 85,240 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:22 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
31,545 | $0 | 79,553 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
31,545 | $0 | 95,327 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:19 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Monia Brett P Chief Executive Officer |
235,133 | $0 | 550,829 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:18 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
35,676 | $0 | 103,932 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:18 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
31,545 | $0 | 93,861 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:17 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
35,676 | $0 | 94,158 (Direct) |
View |
2023-01-15 Option Award |
2023-01-18 8:15 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Baroldi Joseph EVP, Chief Business Officer |
28,839 | $0 | 75,255 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:13 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
23,050 | $0 | 23,050 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:13 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
22,942 | $0 | 22,942 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:13 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
22,942 | $0 | 22,942 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:12 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Monia Brett P Chief Executive Officer |
118,673 | $0 | 118,673 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:12 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
25,946 | $0 | 25,946 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:12 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Geary Richard S EVP, Chief Development Officer |
22,942 | $0 | 22,942 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:12 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
25,946 | $0 | 25,946 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:12 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | BENNETT C FRANK EVP, Chief Scientific Officer |
21,849 | $0 | 21,849 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 6:11 pm |
2024-01-03 2033-01-02 |
IONIS PHARMACEUTICALS INC | IONS | Baroldi Joseph EVP, Chief Business Officer |
22,065 | $0 | 22,065 (Direct) |
View |
2022-10-17 Exercise |
2022-10-18 7:10 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Hayden Michael R Director |
1,777 | $0 | 30,219 (Direct) |
View |
2022-10-17 Exercise |
2022-10-18 7:10 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
416 | $0 | 49,941 (Direct) |
View |
2022-10-17 Tax Withholding |
2022-10-18 7:10 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
144 | $46.52 | 49,941 (Direct) |
View |
2022-10-15 Option Award |
2022-10-18 7:10 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
500 | $0 | 500 (Indirect) |
View |
2022-09-19 Option Award |
2022-09-21 8:08 pm |
2023-09-19 2032-09-18 |
IONIS PHARMACEUTICALS INC | IONS | Swayze Eric EVP Research |
1,000 | $0 | 1,000 (Indirect) |
View |
2022-08-31 Other |
2022-09-01 7:03 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | O'NEIL PATRICK R. EVP CLO & General Counsel |
108 | $28.97 | 34,752 (Direct) |
View |
2022-08-31 Other |
2022-09-01 7:03 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | HOUGEN ELIZABETH L EVP, Finance & CFO |
202 | $28.97 | 58,763 (Direct) |
View |